Skip to main content

Brainstorm Cell Therapeutics Inc.

BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001137883

No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Brainstorm Cell Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
−3 vs. Q3 2024
Shares held
404.0K
−321.7K (−44.3%) vs. Q3 2024Converted for a 1-for-15 split
Total value
$560.3K
−$1.94M (−77.6%) vs. Q3 2024
New holders
14
5 more added
Sold out
17
9 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 34 institutions
Q1 2021: 75 institutionsQ2 2021: 57 institutionsQ3 2021: 52 institutionsQ4 2021: 42 institutionsQ1 2022: 39 institutionsQ2 2022: 48 institutionsQ3 2022: 42 institutionsQ4 2022: 43 institutionsQ1 2023: 48 institutionsQ2 2023: 57 institutionsQ3 2023: 53 institutionsQ4 2023: 46 institutionsQ1 2024: 47 institutionsQ2 2024: 48 institutionsQ3 2024: 38 institutionsQ4 2024: 34 institutionsQ1 2025: 32 institutionsQ2 2025: 34 institutionsQ3 2025: 5 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $560.3K
Q1 2021: $32.1MQ2 2021: $21.4MQ3 2021: $16.9MQ4 2021: $17.6MQ1 2022: $14.0MQ2 2022: $11.0MQ3 2022: $17.1MQ4 2022: $6.16MQ1 2023: $20.4MQ2 2023: $11.5MQ3 2023: $928.4KQ4 2023: $1.04MQ1 2024: $2.19MQ2 2024: $4.09MQ3 2024: $2.52MQ4 2024: $560.3KQ1 2025: $1.09MQ2 2025: $264.0KQ3 2025: $1.73KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BCLI and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20255$1.73K
Q2 202534$264.0K
Q1 202532$1.09M
Q4 202434$560.3K
Q3 202438$2.52M
Q2 202448$4.09M
Q1 202447$2.19M
Q4 202346$1.04M
Q3 202353$928.4K
Q2 202357$11.5M
Q1 202348$20.4M
Q4 202243$6.16M
Q3 202242$17.1M
Q2 202248$11.0M
Q1 202239$14.0M
Q4 202142$17.6M
Q3 202152$16.9M
Q2 202157$21.4M
Q1 202175$32.1M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q3 2024.

Institutions holding BCLI in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc78,441$178.1K0.00%−22,268−22.1%ReducedConverted for a 1-for-15 split
Geode Capital Management, LLC52,501$119.2K0.00%+6,980+15.3%AddedConverted for a 1-for-15 split
BlackRock, Inc.25,172$57.1K0.00%00.0%UnchangedConverted for a 1-for-15 split
Liberty Wealth Management LLC22,666$51.5K0.01%00.0%UnchangedConverted for a 1-for-15 split
HRT Financial LP20,022$45.0K0.00%+20,022New
Weaver Consulting Group15,623$35.5K0.01%00.0%UnchangedConverted for a 1-for-15 split
Two Sigma Securities, LLC11,300$25.7K0.00%+9,980+756.2%AddedConverted for a 1-for-15 split
Ikarian Capital, LLC6,016$13.7K0.00%+6,016New
Morgan Stanley4,317$9.80K0.00%+1,019+30.9%AddedConverted for a 1-for-15 split
UBS Group AG3,472$7.88K0.00%+3,305+1,982.4%AddedConverted for a 1-for-15 split
Citigroup Inc1,971$4.47K0.00%+1,971New
Advisor Group Holdings, Inc.1,915$4.34K0.00%+1,214+173.1%AddedConverted for a 1-for-15 split
Wells Fargo & Company1,338$3.04K0.00%−2,180−62.0%ReducedConverted for a 1-for-15 split
Nelson, Van Denburg & Campbell Wealth Management Group, LLC747$1.70K0.00%00.0%UnchangedConverted for a 1-for-15 split
Activest Wealth Management334$7580.00%00.0%UnchangedConverted for a 1-for-15 split
SBI Securities Co., Ltd.167$3790.00%+167New
Transce3nd, LLC148$3360.00%+148New
EverSource Wealth Advisors, LLC141$3200.00%+141New
VSM Wealth Advisory, LLC120$2720.00%+120New
Steward Partners Investment Advisory, LLC113$2570.00%−67−37.2%ReducedConverted for a 1-for-15 split
FMR LLC111$2520.00%+111New
Bank of America Corp106$2410.00%−1−1.1%ReducedConverted for a 1-for-15 split
Clearstead Advisors, LLC100$2270.00%00.0%UnchangedConverted for a 1-for-15 split
Cranbrook Wealth Management, LLC66$1500.00%+66New
St Germain D J Co Inc33$750.00%−0−1.0%ReducedConverted for a 1-for-15 split
BNP Paribas Arbitrage, SA24$540.00%+24New
Centricity Wealth Management, LLC20$450.00%+20New
CBIZ Investment Advisory Services, LLC13$300.00%+13New
Westside Investment Management, Inc.12$280.00%−1−10.0%ReducedConverted for a 1-for-15 split
Northwestern Mutual Wealth Management Co10$230.00%−1−6.8%ReducedConverted for a 1-for-15 split
CoreCap Advisors, LLC8$180.00%+8New
JPMorgan Chase & Co5$110.00%−7−57.1%ReducedConverted for a 1-for-15 split
Bogart Wealth, LLC2$50.00%−0−11.8%ReducedConverted for a 1-for-15 split
Caldwell Sutter Capital, Inc.157,009$00.00%+157,009New
Armistice Capital, LLC0$00.00%−459,844−100.0%Sold outConverted for a 1-for-15 split
Abner Herrman & Brock LLC0$00.00%−9,700−100.0%Sold outConverted for a 1-for-15 split
State Street Corp0$00.00%−7,817−100.0%Sold outConverted for a 1-for-15 split
Northern Trust Corp0$00.00%−7,491−100.0%Sold outConverted for a 1-for-15 split
Jmac Enterprises LLC0$00.00%−4,362−100.0%Sold outConverted for a 1-for-15 split
XTX Topco Ltd0$00.00%−3,539−100.0%Sold outConverted for a 1-for-15 split
Group One Trading, L.P.0$00.00%−3,117−100.0%Sold outConverted for a 1-for-15 split
Tru Independence Asset Management 2, LLC0$00.00%−2,933−100.0%Sold outConverted for a 1-for-15 split
Tower Research Capital LLC (TRC)0$00.00%−1,557−100.0%Sold outConverted for a 1-for-15 split
Janney Montgomery Scott LLC0$00.00%−1,367−100.0%Sold outConverted for a 1-for-15 split
Creative Planning0$00.00%−923−100.0%Sold outConverted for a 1-for-15 split
Saxony Capital Management, LLC0$00.00%−863−100.0%Sold outConverted for a 1-for-15 split
Bank of New York Mellon Corp0$00.00%−800−100.0%Sold outConverted for a 1-for-15 split
Jump Financial, LLC0$00.00%−733−100.0%Sold outConverted for a 1-for-15 split
Bangor Savings Bank0$00.00%−267−100.0%Sold outConverted for a 1-for-15 split
Reuter James Wealth Management, LLC0$00.00%−69−100.0%Sold outConverted for a 1-for-15 split
Simplex Trading, LLC0$00.00%−77−100.0%Sold outConverted for a 1-for-15 split
Raymond James & Associates––––Not filed